These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29851060)

  • 1. Use of newer antiepileptic drugs and prognosis in adults with status epilepticus: Comparison between 2009 and 2017.
    Fatuzzo D; Novy J; Rossetti AO
    Epilepsia; 2018 Jul; 59(7):e98-e102. PubMed ID: 29851060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Newer Antiepileptic Drugs in Status Epilepticus: Prescription Trends and Outcomes in Comparison with Traditional Agents.
    Beuchat I; Novy J; Rossetti AO
    CNS Drugs; 2017 Apr; 31(4):327-334. PubMed ID: 28337727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer antiepileptic drugs in the treatment of status epilepticus: impact on prognosis.
    Jaques L; Rossetti AO
    Epilepsy Behav; 2012 May; 24(1):70-3. PubMed ID: 22481040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of new versus traditional antiepileptic drugs on course and outcome of status epilepticus.
    Reindl C; Sprügel MI; Sembill JA; Mueller TM; Hagen M; Gerner ST; Kuramatsu JB; Hamer HM; Huttner HB; Madžar D
    Seizure; 2020 Jan; 74():20-25. PubMed ID: 31790940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation.
    Kowalski RG; Ziai WC; Rees RN; Werner JK; Kim G; Goodwin H; Geocadin RG
    Crit Care Med; 2012 Sep; 40(9):2677-84. PubMed ID: 22732291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality, morbidity and refractoriness prediction in status epilepticus: Comparison of STESS and EMSE scores.
    Giovannini G; Monti G; Tondelli M; Marudi A; Valzania F; Leitinger M; Trinka E; Meletti S
    Seizure; 2017 Mar; 46():31-37. PubMed ID: 28226274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of status epilepticus: prognostic role and outcome predictors.
    Tsetsou S; Novy J; Rossetti AO
    Epilepsia; 2015 Mar; 56(3):473-8. PubMed ID: 25580861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment and course of different subtypes of status epilepticus.
    Rantsch K; Walter U; Wittstock M; Benecke R; Rösche J
    Epilepsy Res; 2013 Nov; 107(1-2):156-62. PubMed ID: 24016689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and treatment of refractory status epilepticus in the intensive care unit.
    Drislane FW; Lopez MR; Blum AS; Schomer DL
    J Clin Neurophysiol; 2008 Aug; 25(4):181-6. PubMed ID: 18677181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonconvulsive status epilepticus in adults and children.
    Cascino GD
    Epilepsia; 1993; 34 Suppl 1():S21-8. PubMed ID: 8462490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of outcomes and refractoriness in status epilepticus: A prospective study.
    Atmaca MM; Bebek N; Baykan B; Gökyiğit A; Gürses C
    Epilepsy Behav; 2017 Oct; 75():158-164. PubMed ID: 28866335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.
    Kantanen AM; Reinikainen M; Parviainen I; Kälviäinen R
    Epilepsy Res; 2017 Jul; 133():13-21. PubMed ID: 28402834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Episodes of status epilepticus in young adults: etiologic factors, subtypes, and outcomes.
    Ozdilek B; Midi I; Agan K; Bingol CA
    Epilepsy Behav; 2013 May; 27(2):351-4. PubMed ID: 23537621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early withdrawal of non-anesthetic antiepileptic drugs after successful termination of nonconvulsive seizures and nonconvulsive status epilepticus.
    Creed JA; Son J; Farjat AE; Swisher CB
    Seizure; 2018 Jan; 54():45-50. PubMed ID: 29248799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effectiveness of four antiepileptic drugs in the treatment of status epilepticus according to four different efficacy criteria.
    Redecker J; Wittstock M; Benecke R; Rösche J
    Epilepsy Behav; 2015 Aug; 49():351-3. PubMed ID: 25960425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study.
    Garcés M; Villanueva V; Mauri JA; Suller A; García C; López González FJ; Rodríguez Osorio X; Fernández Pajarín G; Piera A; Guillamón E; Santafé C; Castillo A; Giner P; Torres N; Escalza I; Del Villar A; García de Casasola MC; Bonet M; Noé E; Olmedilla N
    Epilepsy Behav; 2014 Jul; 36():144-52. PubMed ID: 24922617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aborted and refractory status epilepticus in children: a comparative analysis.
    Lambrechtsen FA; Buchhalter JR
    Epilepsia; 2008 Apr; 49(4):615-25. PubMed ID: 18093148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Refractory status epilepticus: effect of treatment aggressiveness on prognosis.
    Rossetti AO; Logroscino G; Bromfield EB
    Arch Neurol; 2005 Nov; 62(11):1698-702. PubMed ID: 16286542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of status epilepticus in elderly patients.
    Vilella L; González Cuevas M; Quintana Luque M; Toledo M; Sueiras Gil M; Guzmán L; Salas Puig J; Santamarina Pérez E
    Acta Neurol Scand; 2018 Mar; 137(3):321-328. PubMed ID: 29168175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with refractoriness and outcome in an adult status epilepticus cohort.
    Ulvin LB; Heuser K; Olsen KB; Taubøll E
    Seizure; 2018 Oct; 61():111-118. PubMed ID: 30125862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.